糖尿病领域的女性领导力差距:呼吁公平与卓越
该研究分析了糖尿病领域女性在ADA年会注册、期刊编委、主要资助项目负责人及奖项获得者中的代表性。结果显示女性在学术性期刊编委、P30中心主任及主要奖项中占比显著偏低,且奖项分布多年未变,呼吁消除女性晋升障碍并促进公平认可。
要点
- 女性在ADA科学年会注册中占43%,但医学与科学主席仅9%为女性。
- 学术型期刊编委女性比例低:Diabetes Care 34%、Diabetes 21%、Diabetologia 30%。
- 仅2-12%的主要ADA、JDRF和EASD奖项授予女性,且随时间无显著变化。
核心结论
- 糖尿病领域在多个领导层面持续存在性别失衡,需减少女性晋升障碍并促进公平认可。
研究设计与样本
- 研究量化了ADA年会注册、ADA与EASD期刊编委、ADA/JDRF/NIH P30资助项目负责人及ADA/JDRF/EASD奖项的性别分布。
主要发现
- 自2016年ADA科学年会注册女性占43%,超五十年间ADA健康教育与护理主席83%为女性。
- ADA医学与科学主席仅9%为女性。
- Diabetes Spectrum编委89%女性,Clinical Diabetes 49%女性,Diabetes Care 34%女性,Diabetes 21%女性,Diabetologia 30%女性。
- 仅三分之一ADA Pathway to Stop Diabetes和JDRF资助授予女性,18个P30糖尿病研究中心中仅2个(11%)由女性领导。
- 主要ADA、JDRF和EASD奖项仅2-12%授予女性,且无显著时间变化。
临床怎么用
- 内分泌科医生应关注学术会议、期刊编委及资助评审中的性别代表性,推动平等参与和认可。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Women are broadly underrepresented in scientific leadership positions and their accomplishments are not provided equal recognition compared with those of men, but the imbalance in the field of diabetes is unknown. Hence, we analyzed multiple aspects of historical and present-day female representation in the diabetes field. RESEARCH DESIGN AND METHODS: We quantified gender representation at annual American Diabetes Association (ADA) meetings; editorial board service positions for ADA and the European Association for the Study of Diabetes (EASD) journals; principal investigators for ADA, JDRF, and National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases P30 grant funding; and ADA, JDRF, and EASD award recipients. RESULTS: There are many women in the field of diabetes: registration for the ADA Scientific Sessions has been 43% female since 2016, and for over five decades, women comprised 83% of ADA Presidents of Health Care and Education. Yet, only 9% of ADA Presidents of Medicine and Science have been women. Women were well represented on editorial boards for journals focused on diabetes education (Diabetes Spectrum, 89% female) and primary care (Clinical Diabetes, 49% female) but not for the more academically targeted Diabetes Care (34% female), Diabetes (21% female), and Diabetologia (30% female). Only one-third of ADA Pathway to Stop Diabetes and JDRF grants have been awarded to women, and females only lead 2 of 18 (11%) of the P30-supported Diabetes Research Centers. Finally, only 2-12% of major ADA, JDRF, and EASD awards were given to women, without significant change over time. CONCLUSIONS: Despite increasing recognition of gender imbalance in research and medicine, many disparities in the field of diabetes persist. We call for decreasing barriers for advancement of female investigators and creating environments that promote their retention and equitable recognition for their contributions to the field.
引用
- Dunne JL, Maizel JL, Posgai AL, et al. The Women's Leadership Gap in Diabetes: A Call for Equity and Excellence. Diabetes Care. 2021. PMID: 34131045. doi:10.2337/dci21-0015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。